PACB
Pacific Biosciences·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
2.71 / 10Overall Score
UnderperformInvestment Rating
2.71 / 10Overall Score
UnderperformInvestment Rating
Trend Analysis of PACB
- Based on a composite score of 2.71/10, we rate PACB as a Underperform. Our analysis breaks down into 0.38/10 for Fundamentals, 2.70/10 for Technicals, and 3.88/10 for Sentiment, indicating the stock is likely to Face downward pressure.
Technical Analysis of PACB?
Is PACB undervalued or overvalued?
Is money flowing into or out of PACB?
Trend Analysis of PACB
- Based on a composite score of 2.71/10, we rate PACB as a Underperform. Our analysis breaks down into 0.38/10 for Fundamentals, 2.70/10 for Technicals, and 3.88/10 for Sentiment, indicating the stock is likely to Face downward pressure.
Is PACB undervalued or overvalued?
Technical Analysis of PACB?
Is money flowing into or out of PACB?
